It's the post-JPM episode
What does President Trump's decision to leave the World Health Organization mean for public health? Should U.S. companies be intimidated by Chinese drug development? And is Elaine tired of Adam and Allison? We discuss all that and more on this week's episode of "The Readout LOUD," a weekly biotech podcast from STAT. First, we go over our closing thoughts from the J.P. Morgan Healthcare Conference, including the chatter around Chinese drugs and a surprise run-in with a past cohost. Then, STAT's infectious disease reporter, Helen Branswell, joins us to explain the implications of Trump's decision to pull the U.S. out of the WHO. Listen Now To learn more about the excitement and anxiety over Chinese drugs being in-licensed by U.S. organizations, go here; to read Allison and Elaine's article on one of VC's preferred China partners and its plans, go here; for Helen's reporting on Trump's decision, go here; And to learn more about what former White House Covid-19 response coordinator Ashish Jha thinks could be reformed at the WHO, check out this First Opinion essay. Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode Visit the archive to see past episodes |
|
| STAT, 1 Exchange Place, Boston, MA | ©2025, All Rights Reserved. | |
|
No comments